CHINA PHARMA HOLDINGS, INC. Notes Payable, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Notes Payable, Current of $0 as of 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2017-03-31
- 2016-12-31: Notes Payable, Current $0.00.
- 2016-09-30: Notes Payable, Current $2.25M.
- 2016-06-30: Notes Payable, Current $4.52M.
- 2016-03-31: Notes Payable, Current $4.65M.
| Period end | Notes Payable, Current |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-31 |
| 2016-09-30 | $2.25M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.52M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $4.65M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $4.62M 10-K · filed 2017-03-31 |
| 2015-09-30 | $4.72M 10-Q · filed 2015-12-28 |
| 2015-06-30 | $4.93M 10-Q · filed 2015-12-28 |
| 2015-03-31 | $4.91M 10-Q · filed 2015-12-28 |
| 2014-12-31 | $4.89M 10-K · filed 2016-03-30 |
| 2014-09-30 | $4.88M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $4.87M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $4.87M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $4.91M 10-K · filed 2015-12-28 |
| 2013-09-30 | $4.89M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $4.86M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $4.79M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $4.76M 10-K · filed 2014-03-20 |
| 2012-09-30 | $3.96M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $3.96M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $3.96M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $3.93M 10-K · filed 2013-03-14 |
| 2011-09-30 | $3.91M 10-Q/A · filed 2012-03-06 |
| 2011-06-30 | $3.87M 10-Q/A · filed 2011-09-06 |
| 2010-12-31 | $3.78M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |